Site marker to be implanted in the breast before neoadjuvant therapy in order to definitively mark the future treated area.
The BiomarC? site marker is a zirconium oxide covered with a carbon coating.
This formulation allows the marker to be permanently visible under MRI as well as X-rays and ultrasound.

- Carbon markers of breast sites treated with adjuvant chemotherapy
- Permanent breast site marker visible on X-rays, ultrasound, CT scan and MRI.
- The marker is released using a manual pusher at the end of a flexible guide.

Technical data:
- Zirconium oxide marker with carbon coating
- 17G manual launcher
- Needle length 11,77 cm
- 0.9x5 mm marker
- Permanent visibility
- Sterile
- CE Class IIb medical device
- Packaged in a box of 10 sterile markers